awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36938779-468D89AC-A493-4B5C-B853-C5884F62B076
Q36938779-468D89AC-A493-4B5C-B853-C5884F62B076
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36938779-468D89AC-A493-4B5C-B853-C5884F62B076
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
P2860
Q36938779-468D89AC-A493-4B5C-B853-C5884F62B076
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36938779-468D89AC-A493-4B5C-B853-C5884F62B076
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddfcbd9ab261775e697473e74bfc1ee45467ba4e
P2860
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.